Profiles

Keywords
Last Name
Institution

Erik Schadde

Concepts (253)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatectomy
36
2021
63
12.610
Why?
Portal Vein
28
2021
47
10.010
Why?
Liver Neoplasms
27
2021
128
9.520
Why?
Liver
19
2021
216
6.770
Why?
Liver Regeneration
16
2020
27
5.850
Why?
Colorectal Neoplasms
12
2020
121
3.890
Why?
Ligation
21
2020
37
2.810
Why?
Embolization, Therapeutic
6
2021
82
2.650
Why?
Hepatic Stellate Cells
2
2020
10
1.590
Why?
Liver Diseases
2
2018
40
1.390
Why?
Cause of Death
3
2017
74
1.300
Why?
Registries
9
2019
203
1.240
Why?
Laparoscopy
5
2019
188
1.190
Why?
Liver Failure
4
2019
13
1.160
Why?
Postoperative Complications
11
2019
1084
1.140
Why?
Carcinoma, Hepatocellular
3
2021
46
1.090
Why?
Hypertrophy
4
2017
20
0.930
Why?
Humans
49
2021
30741
0.920
Why?
Organ Size
9
2019
122
0.920
Why?
Sarcopenia
1
2021
33
0.890
Why?
Treatment Outcome
19
2021
3850
0.870
Why?
Vascular Endothelial Growth Factor A
1
2020
75
0.820
Why?
Neovascularization, Pathologic
1
2020
70
0.810
Why?
Male
36
2021
17552
0.780
Why?
Kidney Transplantation
5
2021
144
0.780
Why?
Organ Sparing Treatments
1
2019
12
0.770
Why?
Hepatomegaly
1
2018
6
0.770
Why?
Reperfusion Injury
1
2018
9
0.760
Why?
Neuroendocrine Tumors
5
2019
45
0.760
Why?
Publication Bias
1
2018
8
0.750
Why?
Bibliometrics
1
2018
20
0.730
Why?
Antioxidants
1
2018
70
0.720
Why?
Reactive Oxygen Species
1
2018
127
0.720
Why?
Oxidative Stress
1
2018
136
0.710
Why?
Retrospective Studies
15
2021
3456
0.700
Why?
Neovascularization, Physiologic
1
2017
30
0.700
Why?
Practice Guidelines as Topic
1
2020
389
0.690
Why?
Middle Aged
26
2019
11256
0.670
Why?
Female
31
2021
18107
0.640
Why?
Therapies, Investigational
1
2016
4
0.640
Why?
Aged
20
2019
10156
0.580
Why?
Graft Rejection
4
2008
85
0.550
Why?
Catheter Ablation
1
2015
78
0.550
Why?
Liver Transplantation
3
2015
110
0.520
Why?
Animals
8
2021
5221
0.510
Why?
Blood Loss, Surgical
3
2019
71
0.500
Why?
Prognosis
8
2020
1045
0.470
Why?
Risk Factors
10
2019
2611
0.470
Why?
Time Factors
9
2019
1911
0.460
Why?
Feasibility Studies
4
2016
283
0.450
Why?
Hepatic Veins
3
2020
9
0.450
Why?
Length of Stay
4
2019
371
0.430
Why?
Operative Time
4
2019
94
0.430
Why?
Survival Rate
6
2018
478
0.420
Why?
Models, Animal
3
2020
150
0.400
Why?
Follow-Up Studies
7
2018
2046
0.400
Why?
Random Allocation
3
2018
162
0.400
Why?
Isoantibodies
2
2006
11
0.390
Why?
Neoplasm Staging
5
2018
516
0.390
Why?
Intestinal Neoplasms
2
2018
13
0.380
Why?
Pancreatic Neoplasms
3
2019
174
0.370
Why?
Antibodies, Neoplasm
1
2008
18
0.370
Why?
Stomach Neoplasms
2
2018
40
0.360
Why?
Swine
2
2018
113
0.360
Why?
Death
1
2008
45
0.360
Why?
Tissue Donors
1
2008
74
0.340
Why?
Rats, Wistar
2
2017
69
0.340
Why?
Vascular Surgical Procedures
2
2019
55
0.340
Why?
Immunosuppressive Agents
1
2008
167
0.330
Why?
Patient Selection
4
2018
259
0.330
Why?
Antibodies, Monoclonal
1
2008
311
0.320
Why?
Antibody Formation
1
2006
32
0.320
Why?
Plasmapheresis
1
2006
17
0.310
Why?
HLA Antigens
1
2006
21
0.310
Why?
Adult
15
2019
9760
0.310
Why?
Rats
2
2020
954
0.310
Why?
Risk Assessment
5
2019
804
0.290
Why?
Philosophy, Medical
1
2004
3
0.290
Why?
Spirituality
1
2004
58
0.270
Why?
Tissue and Organ Procurement
3
2012
36
0.250
Why?
Multivariate Analysis
4
2019
391
0.240
Why?
Cell Proliferation
2
2020
238
0.230
Why?
Xenograft Model Antitumor Assays
1
2021
28
0.230
Why?
Databases, Factual
3
2019
372
0.230
Why?
Gene Expression Regulation, Neoplastic
1
2021
135
0.220
Why?
Severity of Illness Index
2
2019
1233
0.210
Why?
Biliary Tract Neoplasms
1
2020
11
0.210
Why?
Antineoplastic Agents
2
2021
321
0.210
Why?
Adrenalectomy
1
2019
6
0.210
Why?
Brazil
2
2016
32
0.200
Why?
Adrenal Cortex Neoplasms
1
2019
13
0.200
Why?
Adrenocortical Carcinoma
1
2019
12
0.200
Why?
Disease Susceptibility
1
2020
84
0.200
Why?
Chemotherapy, Adjuvant
1
2019
114
0.200
Why?
Ultrasonography
2
2018
204
0.200
Why?
Conversion to Open Surgery
1
2019
4
0.200
Why?
Abdominal Neoplasms
1
2019
13
0.190
Why?
Liver Function Tests
4
2017
32
0.190
Why?
Gallium Radioisotopes
1
2018
3
0.190
Why?
Preoperative Period
1
2019
73
0.190
Why?
bcl-2-Associated X Protein
1
2018
14
0.190
Why?
Culture Media, Conditioned
1
2018
33
0.190
Why?
Paracrine Communication
1
2018
8
0.190
Why?
Cytoprotection
1
2018
12
0.190
Why?
Proto-Oncogene Proteins c-bcl-2
1
2018
33
0.190
Why?
Hepatocytes
1
2018
13
0.190
Why?
Organometallic Compounds
1
2018
25
0.190
Why?
Anesthesia
1
2018
27
0.190
Why?
Hospital Mortality
3
2015
187
0.190
Why?
Digestive System Surgical Procedures
1
2018
27
0.190
Why?
Venous Thrombosis
1
2019
48
0.180
Why?
Pulmonary Embolism
1
2019
56
0.180
Why?
Venous Thromboembolism
1
2019
54
0.180
Why?
Gastric Bypass
1
2018
55
0.180
Why?
Portal Pressure
1
2017
5
0.180
Why?
Liver Circulation
1
2017
6
0.180
Why?
Cell Line, Tumor
1
2018
296
0.170
Why?
Logistic Models
3
2016
479
0.170
Why?
Survival Analysis
2
2017
398
0.170
Why?
Models, Biological
1
2020
428
0.170
Why?
Hyperplasia
1
2017
28
0.170
Why?
Fatty Liver
1
2017
40
0.170
Why?
Tomography, X-Ray Computed
3
2017
876
0.170
Why?
Apoptosis
1
2018
291
0.170
Why?
Melanoma
1
2017
74
0.160
Why?
Cell Hypoxia
1
2016
17
0.160
Why?
Randomized Controlled Trials as Topic
1
2018
361
0.160
Why?
Cholangiocarcinoma
1
2016
8
0.160
Why?
Bile Duct Neoplasms
1
2016
10
0.160
Why?
Reproducibility of Results
1
2019
875
0.160
Why?
Carcinoma, Squamous Cell
1
2017
198
0.150
Why?
Primary Graft Dysfunction
1
2015
3
0.150
Why?
Adenocarcinoma
1
2017
235
0.150
Why?
Methyl Ethers
1
2015
8
0.150
Why?
Anesthetics, Intravenous
1
2015
13
0.150
Why?
Anesthetics, Inhalation
1
2015
12
0.150
Why?
Propofol
1
2015
16
0.150
Why?
Transplantation Conditioning
1
2015
37
0.150
Why?
Obesity
1
2018
322
0.150
Why?
Signal Transduction
1
2018
582
0.150
Why?
Cohort Studies
3
2017
1959
0.150
Why?
Surgeons
1
2016
76
0.140
Why?
Safety
1
2014
57
0.140
Why?
Disease Models, Animal
1
2018
831
0.140
Why?
Neoplasm Invasiveness
1
2014
109
0.140
Why?
Viscera
1
2013
2
0.130
Why?
Vascular Patency
1
2013
26
0.130
Why?
Renal Artery
1
2013
10
0.130
Why?
Aneurysm
1
2013
15
0.130
Why?
Blood Vessel Prosthesis
1
2013
27
0.130
Why?
Blood Vessel Prosthesis Implantation
1
2013
45
0.130
Why?
Pancreas Transplantation
1
2012
9
0.130
Why?
Blood Transfusion
1
2012
68
0.120
Why?
Endovascular Procedures
1
2013
78
0.120
Why?
Bilirubin
2
2016
14
0.120
Why?
Resource Allocation
1
2011
5
0.120
Why?
Health Care Rationing
1
2011
7
0.120
Why?
Linear Models
1
2012
277
0.120
Why?
End Stage Liver Disease
1
2011
17
0.120
Why?
Stents
1
2013
158
0.120
Why?
Histocompatibility Testing
1
2009
6
0.100
Why?
Liver Cirrhosis
2
2012
61
0.100
Why?
HLA-C Antigens
1
2009
9
0.100
Why?
Antilymphocyte Serum
1
2008
8
0.090
Why?
Receptors, Interleukin-2
1
2008
18
0.090
Why?
Minor Histocompatibility Antigens
1
2007
3
0.090
Why?
Disease-Free Survival
2
2019
247
0.090
Why?
Blood Vessels
1
2007
19
0.090
Why?
Immunocompromised Host
1
2008
56
0.090
Why?
Glomerular Filtration Rate
1
2008
75
0.090
Why?
Graft Survival
1
2008
111
0.090
Why?
Switzerland
2
2018
8
0.090
Why?
Heart Transplantation
1
2007
52
0.090
Why?
Kidney Failure, Chronic
1
2009
175
0.090
Why?
Cytomegalovirus Infections
1
2008
84
0.080
Why?
Antibodies, Monoclonal, Humanized
1
2008
137
0.080
Why?
Incidence
2
2021
827
0.080
Why?
CD8-Positive T-Lymphocytes
1
2007
180
0.080
Why?
HLA-DP Antigens
1
2006
1
0.080
Why?
Complement C4b
1
2006
3
0.080
Why?
Body Mass Index
2
2018
438
0.080
Why?
Peptide Fragments
1
2006
121
0.080
Why?
Aged, 80 and over
4
2017
5172
0.070
Why?
Religion and Medicine
1
2004
24
0.070
Why?
Hospitals, University
2
2018
45
0.070
Why?
Naphthoquinones
1
2021
6
0.060
Why?
Benzofurans
1
2021
8
0.060
Why?
Aniline Compounds
1
2021
40
0.060
Why?
Transplant Recipients
1
2021
18
0.060
Why?
Pancreas
1
2021
36
0.060
Why?
Cold Ischemia
2
2011
3
0.060
Why?
Sulfonamides
1
2021
66
0.060
Why?
Mice
2
2021
1843
0.050
Why?
Mitotane
1
2019
3
0.050
Why?
Kidney
1
2021
209
0.050
Why?
Argentina
1
2019
1
0.050
Why?
Preoperative Care
1
2020
149
0.050
Why?
Blood Coagulation Disorders
1
2019
16
0.050
Why?
Digestive System Neoplasms
1
2018
6
0.050
Why?
Postoperative Nausea and Vomiting
1
2018
17
0.050
Why?
Serum Albumin
1
2019
28
0.050
Why?
Thymus Neoplasms
1
2018
14
0.050
Why?
Cytoreduction Surgical Procedures
1
2018
7
0.050
Why?
Europe
1
2019
86
0.050
Why?
Combined Modality Therapy
1
2019
473
0.050
Why?
Neoplasm Metastasis
1
2018
148
0.050
Why?
United States
2
2018
2467
0.050
Why?
Radionuclide Imaging
1
2017
58
0.040
Why?
Gastrointestinal Neoplasms
1
2017
27
0.040
Why?
Salvage Therapy
1
2017
45
0.040
Why?
Postoperative Period
1
2019
293
0.040
Why?
Anticoagulants
1
2019
147
0.040
Why?
Edema
1
2017
39
0.040
Why?
Treatment Failure
1
2017
188
0.040
Why?
Biopsy, Needle
1
2017
122
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
421
0.040
Why?
Italy
1
2016
17
0.040
Why?
Ovarian Neoplasms
1
2017
82
0.040
Why?
Medical Audit
1
2016
8
0.040
Why?
Hospitals, High-Volume
1
2016
10
0.040
Why?
Rabbits
1
2017
327
0.040
Why?
Neoplasm Recurrence, Local
1
2017
230
0.040
Why?
Health Care Surveys
1
2016
76
0.040
Why?
Belgium
1
2015
3
0.040
Why?
Immunohistochemistry
1
2017
501
0.040
Why?
Aspartate Aminotransferases
1
2015
20
0.040
Why?
Age Factors
1
2018
941
0.040
Why?
Sarcoma
1
2017
124
0.040
Why?
Healthcare Disparities
1
2016
79
0.040
Why?
Proportional Hazards Models
1
2016
385
0.040
Why?
Odds Ratio
1
2015
328
0.030
Why?
Predictive Value of Tests
1
2016
631
0.030
Why?
Graft Occlusion, Vascular
1
2013
24
0.030
Why?
Prospective Studies
1
2018
1891
0.030
Why?
Breast Neoplasms
1
2017
440
0.030
Why?
Case-Control Studies
1
2015
694
0.030
Why?
Lung Neoplasms
1
2018
753
0.030
Why?
Waiting Lists
1
2011
19
0.030
Why?
Health Status Indicators
1
2012
82
0.030
Why?
Guidelines as Topic
1
2011
78
0.030
Why?
Magnetic Resonance Imaging
1
2017
1244
0.030
Why?
False Negative Reactions
1
2009
16
0.030
Why?
Immunization
1
2009
49
0.030
Why?
Algorithms
1
2012
421
0.020
Why?
Receptors, CXCR3
1
2007
2
0.020
Why?
Histocompatibility
1
2007
5
0.020
Why?
Mice, Mutant Strains
1
2007
29
0.020
Why?
Child
1
2012
1547
0.020
Why?
Transplantation, Homologous
1
2007
289
0.020
Why?
Wisconsin
1
2006
6
0.020
Why?
Kidney Tubules
1
2006
13
0.020
Why?
Atrophy
1
2006
107
0.020
Why?
Kidney Glomerulus
1
2006
85
0.020
Why?
Schadde's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description